Hypomagnesemia and isoproterenol cardiomyopathies: Protection by probucol

A H Atrakchi1, S Bloom2, B F Dickens1

  • 1Division of Experimental Medicine, The George Washington Medical Center, Washington, D.C., USA.

Insights

Chronic magnesium deficiency causes heart damage, potentially via free radicals. The antioxidant probucol protected against this damage, suggesting free radicals contribute to magnesium deficiency-induced heart injury.

Area of Science:

  • Cardiology
  • Biochemistry
  • Pathology

Background:

  • Chronic magnesium deficiency is linked to damage in cardiac, vascular, and neuronal tissues.
  • The precise mechanisms underlying magnesium deficiency-induced damage are not fully understood.
  • Previous studies suggest a role for free radicals in magnesium deficiency-related myocardial necrosis.

Purpose of the Study:

  • To investigate the hypothesis that free-radical damage contributes to magnesium deficiency-induced myocardial necrosis.
  • To evaluate the protective effects of probucol, an antioxidant agent, against cardiac injury in magnesium-deficient hamsters.

Main Methods:

  • Hamsters were fed a magnesium-deficient diet for 14 days, with or without probucol.
  • Animals received isoproterenol injections to induce cardiac stress.
  • Cardiac lesions were analyzed morphometrically, and serum lipid levels were measured.

Main Results:

  • Probucol significantly reduced the size and number of cardiac lesions induced by both isoproterenol and magnesium deficiency.
  • The protective effect of probucol was attributed to its antioxidant properties, not its lipid-lowering effects.
  • Serum lipid profiles were also assessed in the study.

Conclusions:

  • Free-radical damage likely plays a significant role in magnesium deficiency-induced myocardial necrosis.
  • Probucol's antioxidant activity offers protection against cardiac injury associated with magnesium deficiency.
  • These findings highlight the importance of antioxidant strategies in managing magnesium deficiency-related cardiovascular complications.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.9K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
681
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.4K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
327
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
754